Incorporating immunostimulatory lipids into lipid nanoparticles: exploring expression and immune responses
Open Access
- 25 February 2026
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 223, 115034
Abstract
No abstract availableKeywords
Funding Information
- Innovate UK
This publication has 33 references indexed in Scilit:
- Enhancing RNA encapsulation quantification in lipid nanoparticles: Sustainable alternatives to Triton X-100 in the RiboGreen assayEuropean Journal of Pharmaceutics and Biopharmaceutics, 2024
- Breaking the final barrier: Evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosomeAdvanced Drug Delivery Reviews, 2024
- Structure and Function of Cationic and Ionizable Lipids for Nucleic Acid DeliveryPharmaceutical Research, 2023
- The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potencyJournal of Controlled Release, 2021
- Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluationiScience, 2021
- Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticlesBioengineering & Translational Medicine, 2021
- Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selectionJournal of Controlled Release, 2020
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA VaccinesMolecular Therapy Nucleic Acids, 2019
- Lipid Nanoparticle Systems for Enabling Gene TherapiesMolecular Therapy, 2017
- Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI responseJournal of Controlled Release, 2010